California becomes fifth state to require closed drug formulary for workers' compensation claims | Blog | Verisk Analytics
Formularies are likely to remain a hot topic over the next five years. Almost a dozen other jurisdictions are currently ... that 44 percent of utilization reviews and 35 percent of independent medical reviews involved disputes over pharmaceuticals.iii ... Are Formularies a Viable Solution for Controlling Prescription Drug Utilization and Cost in California Workers' Compensation. ... Are Formularies a Viable Solution for Controlling Prescription Drug Utilization and Cost in California Workers' Compensation. ...https://www.verisk.com/blog/california-becomes-fifth-state-to-require-closed-drug-formulary-for-workers-compensation-claims/
Increase Managed Care Pull-Through Effectiveness: Contracting Strategies, Performance Measurement and communication Training...
In today's pharmaceutical marketplace, companies not only have to fight to win product placement on Managed Care formularies ... KEY TOPICS *Creating a process model for effective response to formulary win *Contracting strategies that support pull-through ... A pharmaceutical product can't find success in the marketplace without formulary access. A well-crafted pull-through plan sets ... Solvay Pharmaceuticals; Xanodyne Pharmaceuticals; Takeda Pharmaceuticals; Smith & Nephew; Novo Nordisk; Galderma; AstraZeneca; ...https://www.best-in-class.com/bestp/domrep.nsf/products/effective-pull-through-organization-engaging-external-stakeholders-performance-measurement?opendocument
Prescription drug prices in the United States - Wikipedia
In reviewing formularies, the drug program reviews the therapeutic advantage of one product over the existing formulary, and ... As of 2013, US "pharmaceutical spending," excluding hospital pharmaceutical spending, was $1,034 per capita in the OECD's ... The high cost of prescription drugs became a major topic of discussion in the new millennium, leading up to the U.S. health ... pharmacy education regarding any changes in the formulary, and patient education within the managed care system. Formularies ...https://en.wikipedia.org/wiki/Prescription_drug_prices_in_the_United_States
Scott's Web Log: The Business of Diabetes: CVS Caremark's Salvo in Biosimilar Insulin for 2017
The CVS Caremark move to drop Sanofi's Lantus from its 2017 formulary is an acknowledgement that big pharma has gotten a little ... Thank you for writing this, and continuing your coverage of this very important topic. I remember reading this many years ago, ... But as a practical reality, given the big cost-savings expected from following the recommended PBM formularies, most companies ... there was a lot of complaining and bellyaching from pharmaceutical and biotechnology companies that there was no regulatory ...http://blog.sstrumello.com/2016/08/the-business-of-diabetes-cvs-caremarks_5.html